Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio A Rodriguez

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Marine Pollution Bulletin|September 20, 2025
High frequency of plastic-derived contaminants (phthalate acid esters) in the preen gland of dead procellariiform seabirds from the Patagonian SeaLuciana Gallo, María Rosa Repetti, Melina Paola Michlig, et al.
Vaccines|October 28, 2023
Large-Scale Purification and Characterization of Recombinant Receptor-Binding Domain (RBD) of SARS-CoV-2 Spike Protein Expressed in YeastGaurav Nagar, Siddharth Jain, Meghraj Rajurkar, et al.
Biotechnology and Bioengineering|November 15, 2024
Adaptation of Aglycosylated Monoclonal Antibodies for Improved Production in Komagataella phaffiiYuchen Yang, Neil C Dalvie, Joseph R Brady, et al.
Biotechnology and Bioengineering|February 24, 2021
Development of a platform process for the production and purification of single-domain antibodiesLaura E Crowell, Chaz Goodwine, Carla S Holt, et al.
Biorxiv : the Preprint Server for Biology|April 21, 2021
Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor binding domain in engineered <i>Komagataella phaffii</i>Neil C Dalvie, Andrew M Biedermann, Sergio A Rodriguez-Aponte, et al.
Biotechnology and Bioengineering|November 15, 2021
Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor-binding domain in engineered Komagataella phaffiiNeil C Dalvie, Andrew M Biedermann, Sergio A Rodriguez-Aponte, et al.
Human Vaccines & Immunotherapeutics|June 6, 2022
Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvantsSakshi Bajoria, Kawaljit Kaur, Ozan S Kumru, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|October 21, 2020
The odyssey of complex neurogenetic disorders: From undetermined to positiveValeria Salinas, Patricia Vega, Luca Marsili, et al.
Nature Communications|December 17, 2025
Engineered antibodies that stabilize drug-modified KRAS<sup>G12C</sup> neoantigens enable selective and potent cross-HLA immunotherapyLorenzo Maso, Sarah A Mosure, Sergio A Rodriguez-Aponte, et al.
Marine Pollution Bulletin|November 1, 2024
High frequency of plastic ingestion in procellariiform seabirds (albatrosses, petrels and shearwaters) in the Southwest Atlantic OceanLuciana Gallo, Patricia P Serafini, Ralph E T Vanstreels, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Marine Pollution Bulletin|September 20, 2025
High frequency of plastic-derived contaminants (phthalate acid esters) in the preen gland of dead procellariiform seabirds from the Patagonian SeaLuciana Gallo, María Rosa Repetti, Melina Paola Michlig, et al.
Vaccines|October 28, 2023
Large-Scale Purification and Characterization of Recombinant Receptor-Binding Domain (RBD) of SARS-CoV-2 Spike Protein Expressed in YeastGaurav Nagar, Siddharth Jain, Meghraj Rajurkar, et al.
Biotechnology and Bioengineering|November 15, 2024
Adaptation of Aglycosylated Monoclonal Antibodies for Improved Production in Komagataella phaffiiYuchen Yang, Neil C Dalvie, Joseph R Brady, et al.
Biotechnology and Bioengineering|February 24, 2021
Development of a platform process for the production and purification of single-domain antibodiesLaura E Crowell, Chaz Goodwine, Carla S Holt, et al.
Biorxiv : the Preprint Server for Biology|April 21, 2021
Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor binding domain in engineered <i>Komagataella phaffii</i>Neil C Dalvie, Andrew M Biedermann, Sergio A Rodriguez-Aponte, et al.
Biotechnology and Bioengineering|November 15, 2021
Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor-binding domain in engineered Komagataella phaffiiNeil C Dalvie, Andrew M Biedermann, Sergio A Rodriguez-Aponte, et al.
Human Vaccines & Immunotherapeutics|June 6, 2022
Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvantsSakshi Bajoria, Kawaljit Kaur, Ozan S Kumru, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|October 21, 2020
The odyssey of complex neurogenetic disorders: From undetermined to positiveValeria Salinas, Patricia Vega, Luca Marsili, et al.
Nature Communications|December 17, 2025
Engineered antibodies that stabilize drug-modified KRAS<sup>G12C</sup> neoantigens enable selective and potent cross-HLA immunotherapyLorenzo Maso, Sarah A Mosure, Sergio A Rodriguez-Aponte, et al.
Marine Pollution Bulletin|November 1, 2024
High frequency of plastic ingestion in procellariiform seabirds (albatrosses, petrels and shearwaters) in the Southwest Atlantic OceanLuciana Gallo, Patricia P Serafini, Ralph E T Vanstreels, et al.
Pageof 4